東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Human iPSC-derived disease models fo...

Kuehn, Markus H.

Linked to FindBook

Google Book

Amazon

博客來

Human iPSC-derived disease models for drug discovery

Record Type:	Electronic resources : Monograph/item
Title/Author:	Human iPSC-derived disease models for drug discovery/ edited by Markus H. Kuehn, Wei Zhu.
other author:	Kuehn, Markus H.
Published:	Cham :Springer International Publishing : : 2023.,
Description:	viii, 332 p. :illustrations (some col.), digital ;24 cm.
[NT 15003449]:	Part 1 General considerations -- Human iPS for clinical applications and cellular products -- 3D-printed iPS disease models -- Part 2 CNS iPSC and organoids -- iPS-derived neurons and brain organoids from patients (brain) -- iPS-derived RGCs (eye) -- iPS-derived glia (brain) -- iPSC to model blood-brain barrier endothelial cells -- Part 3 iPSC-derived nociceptive neurons -- IPSC-based peripheral nerve modeling -- Part 4 Non-neuronal specialized cell types -- iPSC-based drug screening of differentiated cardiomyocyte subtypes -- iPSC-based cardiac disease modeling: from cell to tissue -- iPSC-derived corneal endothelial cell -- iPSC-derived trabecular meshwork (eye) -- iPSC for in vitro disease modeling of diabetes.
Contained By:	Springer Nature eBook
Subject:	Induced pluripotent stem cells - Simulation methods. -
Online resource:	https://doi.org/10.1007/978-3-031-42349-9
ISBN:	9783031423499

Human iPSC-derived disease models for drug discovery
Human iPSC-derived disease models for drug discovery[electronic resource] /edited by Markus H. Kuehn, Wei Zhu. - Cham :Springer International Publishing :2023. - viii, 332 p. :illustrations (some col.), digital ;24 cm. - Handbook of experimental pharmacology,v. 2811865-0325 ;. - Handbook of experimental pharmacology ;v. 281..

Part 1 General considerations -- Human iPS for clinical applications and cellular products -- 3D-printed iPS disease models -- Part 2 CNS iPSC and organoids -- iPS-derived neurons and brain organoids from patients (brain) -- iPS-derived RGCs (eye) -- iPS-derived glia (brain) -- iPSC to model blood-brain barrier endothelial cells -- Part 3 iPSC-derived nociceptive neurons -- IPSC-based peripheral nerve modeling -- Part 4 Non-neuronal specialized cell types -- iPSC-based drug screening of differentiated cardiomyocyte subtypes -- iPSC-based cardiac disease modeling: from cell to tissue -- iPSC-derived corneal endothelial cell -- iPSC-derived trabecular meshwork (eye) -- iPSC for in vitro disease modeling of diabetes.

Since their development a decade ago, human induced pluripotent stem cells (iPSC) have revolutionized the study of human disease, given rise to regenerative medicine technologies, and provided exceptional opportunities for pharmacologic research. These cells provide an essentially unlimited supply of cell types that are difficult to obtain from patients, such as neurons or cardiomyocytes, or are difficult to maintain in primary cell culture. iPSC can be obtained from patients afflicted with a particular disease but, in combination with recently developed gene editing techniques, can also be modified to generate disease models. Moreover, the new techniques of 3 Dimensional printing and materials science facilitate the generation of organoids that can mirror organs under disease conditions. These properties make iPSC powerful tools to study how diseases develop and how they may be treated. In addition, iPSC can also be used to treat conditions in which the target cell population has been lost and such regenerative approaches hold great promise for currently untreatable diseases, including cardiac failure or photoreceptor degenerations.

ISBN: 9783031423499

Standard No.: 10.1007/978-3-031-42349-9doiSubjects--Topical Terms:

3668673
Induced pluripotent stem cells
--Simulation methods.

LC Class. No.: QH588.S83

Dewey Class. No.: 616.02774

Human iPSC-derived disease models for drug discovery
LDR:02969nmm a2200337 a 4500 001 2335920
003 DE-He213
005 20231123220245.0
006 m d
007 cr nn 008maaau
008 240402s2023 sz s 0 eng d
020 $a 9783031423499 $q (electronic bk.)
020 $a 9783031423482 $q (paper)
024 7 $a 10.1007/978-3-031-42349-9 $2 doi
035 $a 978-3-031-42349-9
040 $a GP $c GP
041 0 $a eng
050 4 $a QH588.S83
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
072 7 $a PSAN $2 thema
082 0 4 $a 616.02774 $2 23
090 $a QH588.S83 $b H918 2023
245 0 0 $a Human iPSC-derived disease models for drug discovery $h [electronic resource] / $c edited by Markus H. Kuehn, Wei Zhu.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a viii, 332 p. : $b illustrations (some col.), digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 1865-0325 ; $v v. 281
505 0 $a Part 1 General considerations -- Human iPS for clinical applications and cellular products -- 3D-printed iPS disease models -- Part 2 CNS iPSC and organoids -- iPS-derived neurons and brain organoids from patients (brain) -- iPS-derived RGCs (eye) -- iPS-derived glia (brain) -- iPSC to model blood-brain barrier endothelial cells -- Part 3 iPSC-derived nociceptive neurons -- IPSC-based peripheral nerve modeling -- Part 4 Non-neuronal specialized cell types -- iPSC-based drug screening of differentiated cardiomyocyte subtypes -- iPSC-based cardiac disease modeling: from cell to tissue -- iPSC-derived corneal endothelial cell -- iPSC-derived trabecular meshwork (eye) -- iPSC for in vitro disease modeling of diabetes.
520 $a Since their development a decade ago, human induced pluripotent stem cells (iPSC) have revolutionized the study of human disease, given rise to regenerative medicine technologies, and provided exceptional opportunities for pharmacologic research. These cells provide an essentially unlimited supply of cell types that are difficult to obtain from patients, such as neurons or cardiomyocytes, or are difficult to maintain in primary cell culture. iPSC can be obtained from patients afflicted with a particular disease but, in combination with recently developed gene editing techniques, can also be modified to generate disease models. Moreover, the new techniques of 3 Dimensional printing and materials science facilitate the generation of organoids that can mirror organs under disease conditions. These properties make iPSC powerful tools to study how diseases develop and how they may be treated. In addition, iPSC can also be used to treat conditions in which the target cell population has been lost and such regenerative approaches hold great promise for currently untreatable diseases, including cardiac failure or photoreceptor degenerations.
650 0 $a Induced pluripotent stem cells $x Simulation methods. $3 3668673
650 0 $a Drugs $x Research. $3 685164
650 1 4 $a Neuroscience. $3 917253
650 2 4 $a Regenerative Medicine and Tissue Engineering. $3 3538451
650 2 4 $a Stem Cell Biology. $3 3594097
700 1 $a Kuehn, Markus H. $3 3668671
700 1 $a Zhu, Wei. $3 1928594
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Handbook of experimental pharmacology ; $v v. 281. $3 3668672
856 4 0 $u https://doi.org/10.1007/978-3-031-42349-9
950 $a Biomedical and Life Sciences (SpringerNature-11642)